Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Fight against patent for hepatitis C drug that can cost €55,000

New Scientist - 29 Mar 2017 20:00
Sofosbuvir can cost up to €55,000 for a course of treatment. Charities hope revoking the patent would allow far cheaper generics to cure hepatitis C in Europe
Full Article at New Scientist

More Science News
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard